european stock market


President-elect Donald Trump has tapped Steven Mnuchin, a former Goldman Sachs Group Inc. (NYSE: GS) partner and active movie financier, to be the new Treasury secretary of the United States.

This means the 53-year-old one-time Wall Street banker will soon be the new face of the U.S. economy. And as such, he will cosign our currency, collect our taxes, manage the nation’s debt, and oversee banking regulations.

Keeping these major responsibilities in mind, however, prompted several pundits and politicians to speak out in protest of Mnuchin’s appointment. These critics claimed that such duties can’t be objectively carried out by a former “big banker.” And they took to the Internet to voice their concerns.

european stock market: Critical Elements Corporation (CRECF)


Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    ILC reminds me of Critical Elements [TSXV:CRE] (OTCQX:CRECF) having five projects (CRE has 11), and also of Galaxy Resources (ASX:GXY) (OTCPK:GALXF) by being diversified across brine and spodumene and across three continents. Also some similarity with Neo Lithium’s (OTC:NTTHF) [TSXV:NLC] early stage Argentinean brine project which I recently wrote about here. However, ILC trades at a much smaller market cap of US$8m to that of Critical Elements (US$85m) or Galaxy Resources (US$724m). This is partly due to ILC giving away significant percentages of their projects, and because they are still in the early stages of development.

european stock market: Pacific Gas & Electric Co.(PCG)


Advisors’ Opinion:

  • [By David Dittman]

    PG&E Corp (NYSE: PCG), Edison International (NYSE: EIX) and Sempra Energy (NYSE: SRE) are the parent entities of California’s investor-owned utilities.

european stock market: Aclaris Therapeutics, Inc.(ACRS)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap hair loss stocks Aclaris Therapeutics (NASDAQ: ACRS), Cytori Therapeutics (NASDAQ: CYTX) and RepliCel Life Sciences (OTCQB: REPCF; CVE: RP) are trying to tap into a big market as currently, there are only two FDA-approved drugs available for the treatment of Androgenetic Alopecia (AGA) -also known as male or female pattern baldness (one of which cannot be used by women). Thus, a significant unmet need exists for a safe andefficacious product especially since its experienced by 70% of men and 40% of women as they age.

  • [By Chris Lange]

    Aclaris Therapeutics Inc. (NASDAQ: ACRS) saw its shares make a handy gain on Friday after the company announced the pricing of its secondary offering. The company intends to price its 4 million shares at $22.75 per share, with an overallotment option for an additional 600,000 shares. At this price the entire offering is valued up to $104.65 million.

european stock market: Pure Cycle Corporation(PCYO)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggested small cap water and wastewater services stockPure Cycle Corporation (NASDAQ: PCYO) as a long/bullish trade:

  • [By Lisa Levin]

    In trading on Tuesday, utilities shares fell 0.46 percent. Meanwhile, top losers in the sector included Korea Electric Power Corporation (ADR) (NYSE: KEP), down 4 percent, and Pure Cycle Corporation (NASDAQ: PCYO), down 2 percent.

Leave a Reply

Your email address will not be published. Required fields are marked *